Life-threatening Pneumonitis Induced by Osimertinib Monotherapy as a First-line Treatment for Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer: A Retrospective Case-series Study
Anticancer Research · 2026
DOI: 10.21873/anticanres.18158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Takashi Nojiri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Thoracic Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan; honnnori2003@yahoo.co.jp. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Acrylamides, Aniline Compounds, Lung Neoplasms.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Thoracic Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan; honnnori2003@yahoo.co.jp.
- Department of General Thoracic Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan.
- Department of Palliative Medicine, Himeji St. Mary's Hospital, Himeji, Japan.
- Department of Rheumatology, Higashiosaka City Medical Center, Higashiosaka, Japan.
- Department of Clinical Oncology, Higashiosaka City Medical Center, Higashiosaka, Japan.
- Department of Thoracic Oncology, Kansai Medical University, Hirakata, Japan.
Zitieren
APA
Nojiri, T., Omura, A., Nishimura, H., Uda, H., Katayama, M., Iede, K., Takeyasu, Y., Katsushima, U., Okada, H., & Higashiyama, M. (2026). Life-threatening Pneumonitis Induced by Osimertinib Monotherapy as a First-line Treatment for Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer: A Retrospective Case-series Study. Anticancer Research. https://doi.org/10.21873/anticanres.18158
Vancouver
Nojiri T, Omura A, Nishimura H, Uda H, Katayama M, Iede K, et al. Life-threatening Pneumonitis Induced by Osimertinib Monotherapy as a First-line Treatment for Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer: A Retrospective Case-series Study. Anticancer Research. 2026. doi:10.21873/anticanres.18158
BibTeX
@article{Nojiri2026,
author = {Nojiri, Takashi and Omura, Akiisa and Nishimura, Hiroshi and Uda, Hiroshi and Katayama, Michihito and Iede, Kiyotsugu and Takeyasu, Yuki and Katsushima, Utae and Okada, Hiroshi and Higashiyama, Masahiko},
title = {Life-threatening Pneumonitis Induced by Osimertinib Monotherapy as a First-line Treatment for Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer: A Retrospective Case-series Study},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18158}
}
EUVIMED